U.S. Markets close in 3 hrs 53 mins

Alphamab Oncology (9966.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
16.340+0.120 (+0.74%)
At close: 04:08PM HKT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in HKD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 328.700
52 Week Low 39.900
50-Day Moving Average 317.253
200-Day Moving Average 318.082

Share Statistics

Avg Vol (3 month) 33.2M
Avg Vol (10 day) 34.15M
Shares Outstanding 5935.84M
Implied Shares Outstanding 6N/A
Float 8346.67M
% Held by Insiders 153.91%
% Held by Institutions 119.67%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2020
Most Recent Quarter (mrq)Jun 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-1,090.42%

Management Effectiveness

Return on Assets (ttm)-10.56%
Return on Equity (ttm)-25.77%

Income Statement

Revenue (ttm)42.44M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)-26.80%
Gross Profit (ttm)44.9M
EBITDA -438.76M
Net Income Avi to Common (ttm)-592.03M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.92B
Total Cash Per Share (mrq)2.05
Total Debt (mrq)313.19M
Total Debt/Equity (mrq)15.58
Current Ratio (mrq)5.29
Book Value Per Share (mrq)2.43

Cash Flow Statement

Operating Cash Flow (ttm)-415.36M
Levered Free Cash Flow (ttm)-337.95M